Michael Conick Hanley
Geschäftsführer bei ALTO NEUROSCIENCE, INC.
Vermögen: 47 017 $ am 30.04.2024
Profil
Michael Conick Hanley's current job is Chief Operating Officer at Alto Neuroscience, Inc. His former jobs include Chief Business Officer at Spyre Therapeutics, Inc., Group Vice President-Marketing at Horizon Therapeutics Plc, and Chief Commercial Officer & Vice President at Esteve Pharmaceuticals S.A.
He completed his undergraduate degree at Notre Dame University and holds an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SPYRE THERAPEUTICS, INC
0,00% | 23.02.2023 | 1 448 ( 0,00% ) | 47 017 $ | 30.04.2024 |
ALTO NEUROSCIENCE, INC.
-.--% | 20.05.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Michael Conick Hanley
| Unternehmen | Position | Beginn |
|---|---|---|
| ALTO NEUROSCIENCE, INC. | Geschäftsführer | 20.05.2024 |
Ehemalige bekannte Positionen von Michael Conick Hanley
| Unternehmen | Position | Ende |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Corporate Officer/Principal | 14.04.2023 |
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Corporate Officer/Principal | 01.09.2019 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Vertrieb & Marketing | 01.06.2017 |
Ausbildung von Michael Conick Hanley
| Kellogg School of Management | Masters Business Admin |
| Notre Dame University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| ALTO NEUROSCIENCE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
